Precision Oncology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
61
NCT05532696
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 27, 2022
Completion: May 31, 2027
Loading map...